Pinnacle West Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Hold
16,158
0.27% 76
2026
Q1
$454K Sell
16,158
-25
-0.2% -$666 0.31% 78
2025
Q4
$403K Buy
16,183
+225
+1% +$5.67K 0.26% 83
2025
Q3
$407K Buy
15,958
+308
+2% +$7.6K 0.26% 85
2025
Q2
$379K Sell
15,650
-510
-3% -$11.9K 0.26% 82
2025
Q1
$409K Buy
16,160
+1,135
+8% +$29.7K 0.3% 83
2024
Q4
$399K Buy
15,025
+350
+2% +$9.49K 0.29% 82
2024
Q3
$425K Buy
14,675
+775
+6% +$22.6K 0.3% 81
2024
Q2
$389K Buy
13,900
+500
+4% +$13.8K 0.3% 80
2024
Q1
$372K Buy
13,400
+150
+1% +$4.16K 0.3% 81
2023
Q4
$381K Buy
13,250
+850
+7% +$25.7K 0.33% 79
2023
Q3
$411K Buy
12,400
+1,525
+14% +$53.9K 0.4% 69
2023
Q2
$399K Sell
10,875
-150
-1% -$5.84K 0.39% 72
2023
Q1
$450K Buy
+11,025
New +$476K 0.47% 69

Other funds holding PFE

Pinnacle West Asset Management's PFE Position: Q2 2026 in Review

Pinnacle West Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 16,158 shares worth $389K. The position accounts for 0.27% of the portfolio, ranked #76.

Pinnacle West Asset Management first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $454K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pinnacle West Asset Management held 16,158 shares of Pfizer worth $389K as of Q2 2026.
  • Pinnacle West Asset Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.27% of Pinnacle West Asset Management's portfolio in Q2 2026, its #76 holding.
  • Pinnacle West Asset Management first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Pinnacle West Asset Management's Pfizer position peaked at $454K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pinnacle West Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.